Longitudinal increase in the detection rate of Mycobacterium chimaera in heater-cooler device-derived water samples

Autor: Schreiber, P.W. ^{a, ∗}, Zihlmann, R. ^b, Schärer, V. ^a, Hasse, B. ^a, Imkamp, F. ^{c, d}, Schulthess, B. ^{c, d}, Sander, P. ^{c, d}, Zingg, W. ^a

Publikováno v: In Journal of Hospital Infection January 2023 131:190-193

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass

Autor: Baddour, L.M. ^ay, Diekema, D. ^az, Fernández-Hidalgo, N. ^ba, Gordon, S. ^bb, Hasse, B. ^bc, Lundgren, J. ^bd, Manfrin, V. ^be, Nomura, J. ^bf, Scriven, J. ^bg, Stewart, R. ^bh, Wagner, D. ^bi, Tang, T.H.-C. ^bj, Herwaldt, L.A. ^bk, Mertz, D. ^bl, Sax, H. ^bm, Schreiber, P. ^bm, Sommerstein, R. ^bn, Stewardson, A. ^bo, Whitener, C.J. ^bp, Widmer, A. ^bq, Brown Elliot, B.A. ^br, Daley, C. ^bs, Freiberger, T. ^bt, van Ingen, J. ^bu, Keller, P. ^bv, Kohl, T.A. ^bw, Maurer, F. ^bx, Niemann, S. ^by, Wallace, R.J., Jr. ^br, Falk, V. ^bz, Halbe, M. ^ca, Mestres, C.A. ^cb, Zweifel, S. ^cb, Bettex, D. ^cc, Hernandez Conte, A. ^cd, Chand, M. ^ce, Jarashow, M.C. ^cf, Lamagni, T. ^cg, Plachouras, D. ^cf, Perkins, K.M. ^ch, Hannan, M.M. ^b, Keller, P.M. ^c, Maurer, F.P. ^d, Durante-Mangoni, E. ^m, Stuart, R.L. ^o, Schreiber, P.W. ^a, Daley, C.L. ^t, Stewardson, A.J. ^u, Perkins, K. ^w, Sander, P. ^ac, Schulthess, B. ^ad, Scriven, J.E. ^ae, Brown-Elliott, B.A. ^ai, Miro, J.M. ^{ak, 1}, Hoen, B. ^{al, ∗∗, 1}, Athan, E. ^am, Bayer, A. ^an, Barsic, B. ^ao, Corey, G.R. ^ap, Chu, V.H. ^aq, Durack, D.T. ^aq, Fortes, C.Q. ^ar, Fowler, V. ^as, Krachmer, A.W. ^au, Durante-Magnoni, E. ^av, Wilson, W.R. ^ax

Publikováno v: In Journal of Hospital Infection February 2020 104(2):214-235

Clinical and genomic features of Mycobacterium avium complex: a multi-national European study.

Autor: Wetzstein N; Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital, Theodor-Stern-Kai 7, FrankfurtFrankfurt Am Main, 60590, Germany. wetzstein@med.uni-frankfurt.de.; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany. wetzstein@med.uni-frankfurt.de.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany. wetzstein@med.uni-frankfurt.de., Diricks M; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany., Anton TB; Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital, Theodor-Stern-Kai 7, FrankfurtFrankfurt Am Main, 60590, Germany., Andres S; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany., Kuhns M; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany., Kohl TA; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany., Schwarz C; Division of Cystic Fibrosis, CF Center Westbrandenburg, Campus Potsdam, Klinikum Potsdam, Potsdam, Germany., Lewin A; Unit Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, Berlin, Germany., Kehrmann J; Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Kahl BC; Institute of Medical Microbiology, University Hospital Münster, Münster, Germany., Schmidt A; Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Institute for Medical Microbiology and Hygiene, University Hospital Tübingen, Tübingen, Germany., Zimmermann S; Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany., Jansson MK; Institute of Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany., Baron SA; Faculté de Médecine Et de Pharmacie, IRD, APHM, Aix Marseille Univ, MEPHI, IHU Méditerranée Infection, Marseille, France., Schulthess B; National Reference Laboratory for Mycobacteria, Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland., Hogardt M; Institute of Medical Microbiology and Infection Control, Goethe University, University Hospital, FrankfurtFrankfurt Am Main, Germany.; German National Consiliary Laboratory On Cystic Fibrosis Bacteriology, Frankfurt Am Main, Germany., Friesen I; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany., Niemann S; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany., Wichelhaus TA; Institute of Medical Microbiology and Infection Control, Goethe University, University Hospital, FrankfurtFrankfurt Am Main, Germany.

Publikováno v: Genome medicine [Genome Med] 2024 Jul 09; Vol. 16 (1), pp. 86. Date of Electronic Publication: 2024 Jul 09.

Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.

Autor: Schulthess B; Institute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland schulthe@imm.uzh.ch.; National Reference Center for Mycobacteria, Gloriastrasse 28/30, 8006 Zurich, Switzerland., Schäfle D; Institute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland., Kälin N; Institute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.; National Reference Center for Mycobacteria, Gloriastrasse 28/30, 8006 Zurich, Switzerland., Widmer T; Institute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.; National Reference Center for Mycobacteria, Gloriastrasse 28/30, 8006 Zurich, Switzerland., Sander P; Institute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.; National Reference Center for Mycobacteria, Gloriastrasse 28/30, 8006 Zurich, Switzerland.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 May 01; Vol. 65 (5). Date of Electronic Publication: 2021 Feb 22.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.